Cogent Biosciences, Inc. (COGT) vs PTC Therapeutics, Inc. (PTCT)

A side-by-side comparison of Cogent Biosciences, Inc. and PTC Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COGT vs PTCT

growth of $100 · dividends reinvested · last 9y
COGT -30.5% (-4.0%/yr)PTCT +99.4% (+8.0%/yr)PTCT compounded faster over this window
0100200Start $1002020202220242026$69$199
COGT PTCT

COGT vs PTCT: by the numbers

  • •PTCT is the larger company ($5.31B vs $5.18B market cap).
  • •Both run net losses; COGT's is the smaller (0.00% vs -3.80% net margin).

Metrics side by side

Valuation

MetricCOGTPTCT
Forward P/EN/A50.08
P/S ratioN/A5.27
P/B ratio11.08N/A
EV / EBITDAN/A28.90

Profitability

MetricCOGTPTCT
Gross margin0.00%95.85%
Operating margin0.00%49.49%
Net margin0.00%-3.80%
ROE-70.85%N/A
ROIC-50.09%4.59%

Growth (annualized)

MetricCOGTPTCT
Revenue CAGR (5Y)N/A16.41%
Total return CAGR (5Y)28.51%11.75%

Frequently asked

How have COGT and PTCT total returns compared?
Over the past 5 years, COGT delivered 28.51% and PTCT delivered 11.75% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.